Pharmacotherapeutics in clinical ethology: treatment efficacy, clinical pathology and outcome
In: BehaviourSearch for other papers by Karen L. Overall in
Current site
Google Scholar
Abstract
The use of psychopharmaceutical agents is a core aspect of treatment in veterinary behavioural medicine. Psychotropic medication use has shifted the focus of treatment from purely behavioural and environmental interventions to a multi-modal approach. Objective measures of efficacy are required for the licensing of medication. Pharmacotherapeutics have come to encompass supplements and diets, in addition to prescription medications. The first part of this paper examines the efficacy of medications, supplements and diets used in behavioural medicine. Foci include the role of evolution in the types of behavioural concerns reported, the importance of defining abnormal or pathological behaviour, use of terminology that supports stratified mechanistic diagnoses aid in understanding presentation and response clusters, and rational use of medication to relieve emotional, mental and behavioural suffering, given these diagnoses and clusters. The second part of this paper examines the extent to which variation in patient response to medication can enlighten us about mechanisms and outcomes of distress using a series of 3 patient populations who are the focus of studies on separation anxiety and noise reactivity. This response surface approach can be useful for understanding differences in populations in susceptibility to behavioural pathology and in medication response, and may suggest new avenues for drug development and application.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Araujo, J.A., de Rivera, C., Ethie, J.L., Landsberg, G.M., Denenberg, S., Arnold, S. & Milgram, N.W. (2010). ANXITANE® tablets reduce fear of human beings in a laboratory model of anxiety-related behavior. — J. Vet. Behav.: Clin. Appl. Res. 5: 268-275.
-
Bamberger, M. & Houpt, K.A. (2006). Signalment factors, comorbidity, and trends in behavior diagnoses in dogs: 1,644 cases (1991–2001). — J. Am. Vet. Med. Ass. 229: 1591-1601.
-
Beata, C., Beaumont-Graff, E., Diaz, C., Marion, M., Massal, M., Marlois, N., Muller, G. & Lefranc, C. (2007a). Effects of alpha-casozepine (Zylkene) versus selegiline hydrochloride (Selgian, Anipryl) on anxiety disorders in dogs. — J. Vet. Behav.: Clin Appl. Res. 2: 175-183.
-
Beata, C., Beaumont-Graff, E., Coll, V., Cordel, J., Marion, M., Massal, N., Marlois, N. & Tauzin, J. (2007b). Effect of alpha-casozepine (Zylkene) on anxiety in cats. — J. Vet. Behav.: Clin. Appl. Res. 2: 40-46.
-
Bellamy, K.K.L., Storengen, L.M., Handegård, K.W., Arnet, E.F., Prestrud, K.W., Overall, K.L. & Lingaas, F. (2018). DRD2 is associated with fear in some dog breeds. — J. Vet. Behav.: Clin Appl. Res. 27: 67-73.
-
Campbell, N.G., Shekar, A., Aguilar, J.I., Peng, D., Navratna, V., Yang, D., Morley, A.N., Duran, A.M., Galli, G., O’Grady, B., Ramachandran, R., Sutcliffe, J.S., Sitte, H.H., Erreger, K., Meiler, J., Stockner, T., Bellan, L.M., Matthies, H.J.G., Gouaux, E., Mchaourab, H.S. & Galli, A. (2019). Structural, functional, and behavioral insights of dopamine dysfunction revealed by a deletion in SLC6A3. — Proc. Natl Acad. Sci. USA 116: 3853-3862.
-
Castellanos, F.X. & Tannock, R. (2002). Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. — Nature Neurosci. 3: 617-628.
-
Chicoine, A., Vuong, S., Illing, K., Hare, J., Caldwell, J. & Sandler, I. (2020). Composition of unapproved cannabinoid products directly marketed to Canadian pet owners. — Can. Vet. J. 61: 477-480.
-
Cooper, J.J. & Mason, G.J. (1998). The identification of abnormal behaviour and behavioural problems in stabled horses and their relationship to horse welfare: a comparative review. — Equine Vet. J. Suppl. 27: 5-9.
-
Corsetti, S., Borruso, S., Malandrucco, L., Spallucci, V., Maragliano, L., Perino, R., D’Agostino, P. & Natoli, E. (2021). Cannabis sativa L. may reduce aggressive behaviour towards humans in shelter dogs. — Sci. Rep. 11: 2773. https://doi.org/10.1038/s41598-021-82439-2.
-
Crowell-Davis, S., Seibert, L., Sung, W., Parthasarathy, V. & Curtis, T. (2003). Use of clomipramine, alprazolam, and behavior modification for treatment of storm phobia in dogs. — J. Am. Vet. Med. Ass. 222: 744-748. https://doi.org/10.2460/javma.2003.2.22.744.
-
Curtis, T.M., Knowles, R.J. & Crowell-Davis, S.L. (2003). Influence of familiarity and relatedness on proximity and allogrooming in domestic cats (Felis catus). — Am. J. Vet. Res. 64: 1151-1154.
-
Davis, M. (1997). Neurobiology of fear responses: the role of the amygdala. — J. Neuropsychiatr. Clin. 9: 382-402.
-
De Porter, T.L., Landsberg, G.M., Araujo, J.A., Eithier, J.L. & Bledso, D.L. (2012). Haromonease Chewable Tablets reduces noise-induced fear and anxiety in a laboratory canine thunderstorm situation: a blinded and placebo controlled study. — J. Vet. Behav.: Clin. Appl. Res. 7: 225-232.
-
Diesel, G., Brodbelt, D. & Pfeiffer, D.U. (2010). Characteristics of relinquished dogs and their owners at 14 rehoming centers in the United Kingdom. — J. Appl. Anim.Welf. Sci. 13: 15-30.
-
Dinwoodie, I.R., Dwyer, B., Zottola, V., Gleason, D. & Dodman, N.H. (2019). Demographics and comorbidity of behavior problems in dogs. — J. Vet. Behav.: Clin. Appl. Res. 32: 62-71. https://doi.org/10.1016/j.jveb.2019.04.007.
-
Dockx, R., Baeken, C., De Bundel, D., Saunders, J.H., Van Eeckhaut, A. & Peremans, K. (2019). Accelerated high-frequency repetitive transcranial magnetic stimulation positively influences the behavior, monaminergic system, and cerebral perfusion in anxious aggressive dogs: A case study. — J. Vet. Behav.: Clin. Appl. Res. 33: 108-113.
-
Dodman, N.H., Karlsson, E.K., Moon-Fanelli, A., Galdzick, M., Perloski, M., Shuster, L., Lindblad-Toh, K. & Ginns, E.I. (2010). A canine chromosome 7 locus confers compulsive disorder susceptibility. — Mol. Psychiatr. 15: 8-10.
-
Dolan, E.D., Scotto, J., Slater, M. & Weiss, E. (2015). Risk factors for dog relinquishment to a Los Angeles municipal animal shelter. — Animals 5: 1311-1328.
-
Dramard, V., Kern, L., Hofmans, J., Rème, C.A., Nicolas, C.S., Chala, V. & Navarro, C. (2018). Effect of l-theanine tablets in reducing stress-related emotional signs in cats: an open-label field study. — Irish Vet. J. 71: 21.
-
Engel, O., Müller, H.W., Klee, R., Francke, B. & Mills, D.S. (2019). Effectiveness of imepitoin for the control of anxiety and fear associated with noise phobia in dogs. — J. Vet. Intern. Med. 33: 2675-2684.
-
Erickson, A., Harbin, K., MacPherson, J., Rundle, K. & Overall, K.L. (2021). A review of pre-appointment medications to reduce fear and anxiety in dogs and cats at veterinary visits. — Can. Vet. J. In press.
-
Fahnestock, M., Marchese, M., Head, E., Pop, V., Michalski, B., Milgram, N.W. & Cotman, C.W. (2012). BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. — Neurobiol. Aging 33: 546-554.
-
Finniss, D.G., Kaptchuk, T.J., Miller, F. & Benedetti, F. (2010). Placebo effects: biological, clinical and ethical advances. — Lancet 375: 686-695.
-
Gilbert-Gregory, S.H., Stull, J.W., Rice, M.R. & Herron, M.E. (2016). Effects of trazodone on behavioral signs of stress in hospitalized dogs. — J. Am. Vet. Med. Ass. 249: 1281-1291.
-
Goodwin, D. (1999). The importance of ethology in understanding the behaviour of the horse. — Equine Vet. J. Suppl. 28: 15-19.
-
Gottesman, I.I. & Shields, J. (1972). Schizophrenia and genetics: a twin study vantage point. — Academic Press, New York, NY.
-
Graeff, F.G., Silviera, M.C.L., Nogueira, R.L., Audi, E.A. & Oliveira, R.M.W. (1993). Role of the amygdala and the periaqueductal gray in anxiety and panic. — Behav. Brain Res. 58: 123-131.
-
Gruen, M.E., Roe, S.E., Griffith, E., Hamilton, A. & Sherman, B.L. (2014). The use of trazodone to facilitate post-surgical confinement in dogs. — J. Am. Vet. Med. Ass. 245: 296-301. DOI:10.2460/javma.245.3.296.
-
Gruen, M.E., Roe, S.C., Griffith, E.H. & Sherman, B.L. (2017). The use of trazodone to facilitate calm behavior after elective orthopedic surgery in dogs: results and lessons learned from a clinical trial. — J. Vet. Behav.: Clin. Appl. Res. 22: 41-45. https://doi.org/10.1016/j.jveb.2017.09.008.
-
Handegård, K.W., Storengen, L.M. & Lingaas, F. (2020). Noise reactivity in standard poodles and Irish soft-coated wheaten terriers. — J. Vet. Behav.: Clin. Appl. Res. 36: 4-12.
-
Hauser, H., Campbell, S., Korpivaara, M., Stefanovski, D., Quinlan, M. & Siracusa, C. (2020). In-hospital administration of dexmedetomidine oromucosal gel for stress reduction in dogs during veterinary visits: a randomized, double-blinded, placebo-controlled study. — J. Vet. Behav.: Clin. Appl. Res. 39: 77-85.
-
Hewson, C.J., Conlon, P.D., Luescher, U.A. & Ball, R.O. (1998). The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine. — J. Vet. Pharmacol. Therap. 21: 214-222.
-
Houpt, K.A., Honig, S.U. & Reisner, I.R. (1996). Breaking the human-companion animal bond. — J. Am. Vet. Med. Ass. 208: 1653-1659.
-
Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D.S., Quinn, K., Sanislow, C. & Wang, P. (2010). Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. — Am. J. Psychiatr. 167: 748-751.
-
Insel, T.R. (2014). The NIMH Research Domain Criteria (RDoC) project: precision medicine for psychiatry. — Am. J. Psychiatr. 171: 4.
-
Kapur, S., Phillips, A.G. & Insel, T.R. (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? — Mol. Psychiatry 17: 1174-1179.
-
Kellner, M. & Yehuda, R. (1999). Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology? — Psychoneuroendocrinology 24: 485-504.
-
Kim, J.J. & Diamond, D.M. (2002). The stressed hippocampus, synaptic plasticity and lost memories. — Nature Rev. Neurosci. DOI:10.1038/nrn849.
-
King, J., Simpson, B., Overall, K.L., Appleby, D., Pageat, P., Ross, C., Chaurand, J.P., Heath, S., Beata, C., Weiss, A.B., Muller, G., Paris, T., Bataille, B.G., Parker, J., Petit, S. & Wren, J. (2000b). Treatment of separation anxiety in dogs with clomipramine. Results from a prospective, randomized, double-blinded, placebo-controlled clinical trial. — Appl. Anim. Behav. Sci. 67: 255-275.
-
King, J.N., Maurer, M.P., Altmann, B.O. & Strehlau, G.A. (2000a). Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration. — Am. J. Vet. Res. 61: 80-85.
-
King, J.N., Overall, K.L., Appleby, D., Simpson, B.S., Beata, C., Chaurand, C.J.P., Heath, S.E., Ross, C., Weiss, A.B., Muller, G., Bataille, B.G., Paris, T., Pageat, P., Brovedani, F., Garden, C. & Petit, S. (2004). Results of a follow-up investigation to a clinical trial testing the efficacy of clomipramine in the treatment of separation anxiety in dogs. — Appl. Anim. Behav. Sci. 89: 233-242.
-
Korpivaara, M., Laapas, K., Huhtinen, M., Schöning, B. & Overall, K.L. (2017). Dexmedetomidine oromucosal gel for noise associated acute anxiety and fear in dogs — a randomised, double-blind, placebo-controlled clinical study. — Vet. Rec. DOI:10.1136/vr.104045.
-
Landsberg, G., Milgram, B., Mougeot, I., Kelly, S. & de Rivera, C. (2017). Therapeutic effects of an alpha-casozepine and L-tryptophan supplemented diet on fear and anxiety in the cat. — J. Feline Med. Surg. 19: 594-602.
-
Landsberg, G.M., Melese, P., Sherman, B.L., Neilson, J.C., Zimmerman, A. & Clarke, T.P. (2008). Effectiveness of fluoxetine chewable tablets in the treatment of canine separation anxiety. — J. Vet. Behav.: Clin. Appl. Res. 3: 12-19.
-
Li, Y., Holdt, B.M., Reynolds, A., Boyko, A.R., Wayne, R.K., Wu, D.D. & Zhang, Y.P. (2013). Artificial selection on brain-expressed genes during the domestication of dog. — Mol. Biol. Evol. 30: 1867-1876.
-
Maddock, R.J., Buonocore, M.H., Copeland, L.E. & Richards, A.L. (2009). Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. — Molec. Psychiatry 14: 537-545.
-
Mahar, I., Bambico, F.R., Mechawar, N. & Nobrega, J.N. (2014). Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. — Neurosci. Biobehav. Rev. 38: 173-192.
-
Marston, L.C., Bennett, P.C. & Coleman, G.J. (2004). What happens to shelter dogs? An analysis of data for 1 year from three Australian shelters. — J. Appl. Anim.Welf. Sci. 7: 27-47.
-
McPeake, K.J. & Mills, D.S. (2017). The use of imepitoin (Pexion™) on fear and anxiety related problems in dogs — a case series. — BMC Vet.Res. 13: 173. DOI:10.1186/s12917-017-1098-0.
-
McTavish, D. & Benfield, P. (1990). Clomipramine: an vverview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. — Drugs 39: 136-153.
-
Mendl, M., Brooks, J., Basse, C., Burman, O., Paul, E., Blackwell, E. & Casey, R. (2010). Dogs showing separation-related behaviour exhibit a ‘pessimistic’ cognitive bias. — Curr. Biol. 20: R840.
-
Meneses, T., Robinson, J., Rose, J., Vernick, J. & Overall, K.L. (2021). Paradigm shifts in our knowledge of separation anxiety. Part I: a review of contributory factors separating myth from fact. — J. Am. Vet. Med. Ass.. In press.
-
Michelazzi, M., Berteselli, G.V., Talamonti, Z., Cannas, S., Scaglia, E., Minero, M. & Palestrini, C. (2015). Efficacy of L-theanine in the treatment of noise phobias in dogs: preliminary results. — Veterinaria 29: 1-7.
-
Milgram, N.W., Head, E., Zicker, S.C., Ikeda-Douglas, C.J., Murpey, H., Muggenburg, B., Siwak, C., Tapp, D. & Cotman, C.W. (2005). Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: a two-year longitudinal study. — Neurobiol. Aging 26: 77-90.
-
Nestler, E.J., Terwilliger, R.Z. & Duman, R.S. (1989). Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. — J. Neurochem. 53: 1644-1647.
-
Niciu, M.J., Ionescu, D.F., Mathews, D.C., Richards, E.M. & Zarate Jr., C.A. (2013). Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder. — CNS Spectrum 18: 231-241.
-
Normando, S., Meers, L., Samuels, W.E., Faustini, M. & Ödberg, F. (2011). Variables affecting the prevalence of behavioural problems in 98 horses. Can riding style and other management factors be significant? — Appl. Anim. Behav. Sci. 133: 186-198.
-
Ogata, N. & Dodman, N.H. (2010). The use of clonidine in the treatment of fear-based behavior problems in dogs: an open trial. — J. Vet. Behav.: Clin. Appl. Res. 6: 130-137.
-
Orlando, J.M., Case, B.C., Thomson, A.E., Griffith, E. & Sherman, B.L. (2015). Use of oral trazodone for sedation in cats: a pilot study. — J. Feline Med. Surg. 18: 476-482.
-
Overall, K.L. (1994). Use of clomipramine to control ritualistic motor behavior in dogs. — J. Am. Vet. Med. Ass. 205L: 1733-1741.
-
Overall, K.L. (1997). Clinical behavioral medicine for small animals. — Mosby, St. Louis, MO.
-
Overall, K.L. (2000). Dogs as “natural” models of human psychiatric disorders: assessing validity and understanding mechanism. — Prog. Neuropsychopharmacol. Biol. Psychiat. 24: 727-776.
-
Overall, K.L. (2001). Pharmacological treatment in behavioral medicine: the importance of neurochemistry, molecular biology, and mechanistic hypotheses. — Vet. J. 162: 9-23.
-
Overall, K.L. (2005). Veterinary behavioural medicine: a roadmap for the 21st century. — Vet. J. 169: 130-143.
-
Overall, K.L. (2013). Manual of clinical behavioral medicine. — Elsevier, St. Louis, MO.
-
Overall, K.L. (2017). Behavior medications — which medication, which patient? — Todays Vet. Pract. 7: 96-104.
-
Overall, K.L. (2019). Behavioral pharmacotherapeutics. — In: Pharmacotherapeutics for veterinary dispensing (Mealey, K.L., ed.). Wiley Blackwell, Hoboken, NJ, p. 377-402.
-
Overall, K.L. & Dunham, A.E. (2002). Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989–2000). — J. Am. Vet. Med. Ass. 221: 1445-1452.
-
Overall, K.L. & Dunham, A.E. (2009). Homeopathy and the curse of the scientific method. — Vet. J. 180: 140-148.
-
Overall, K.L., Dunham, A.E. & Frank, D. (2001). Frequency of nonspecific clinical signs in dogs with separation anxiety, thunderstorm phobia, and noise phobia, alone or in combination. — J. Am. Vet. Med. Ass. 219: 467-473. https://doi.org/10.2460/javma.2001.219.467.
-
Overall, K.L., Dunham, A.E. & Juarbe-Diaz, S.V. (2016). Phenotypic determination of noise reactivity in 3 breeds of working dogs: roles for age, breed and careful assessment. — J. Vet. Behav.: Clin. Appl. Res. 16: 113-125. https://doi.org/10.1016/j.jveb.2016.09.007.
-
Overall, K.L., Dunham, A.E., Scheifele, P. & Sonstrom Malowski, K. (2019). Fear of noises affects canine problem solving behavior and locomotion in standardized cognitive tests. — Appl. Anim. Behav. Sci. https://doi.org/10.1016/j.applanim.2019.104863.
-
Palestrini, C., Minero, M., Cannas, S., Berteselli, G., Scaglia, E., Barbieri, S., Cavallone, E., Puricelli, M., Servida, F. & Dall’Ara, P. (2010). Efficacy of a diet containing caseinate hydrolysate on signs of stress in dogs. — J. Vet. Behav.: Clin. Appl. Res. 5: 309-317.
-
Pan, Y., Larson, B., Araujo, J.A., Lau, W., de Rivera, C., Santana, R., Gore, A. & Milgram, N.W. (2010). Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. — Br. J. Nutr. 103: 1746-1754. DOI:10.1017/S0007114510000097.
-
Pike, A.L., Horwitz, D.F. & Lobprise, H. (2015). An open-label prospective study of the use of l-theanine (Anxitane) in storm-sensitive client-owned dogs. — J. Vet. Behav.: Clin. Appl. Res. 10: 324-331.
-
Roberts, L.W., Chan, S. & Torous, J. (2018). New tests, new tools: mobile and connected technologies in advancing psychiatric diagnosis. — npj Digital Med. 1: 20176. DOI:10.1038/s41746-017-0006-0.
-
Rose, P.E., Nash, S.M. & Riley, L.M. (2017). To pace or not to pace? A review of what abnormal repetitive behavior tells us about zoo animal management. — J. Vet. Behav.: Clin. Appl. Res. 20: 11-21.
-
Saetre, P., Lindberg, J., Leonard, J.A., Olsson, K., Pettersson, U., Ellegren, H., Bergström, T.F., Vil, C. & Jazin, E. (2004). From wild wolf to domestic dog: gene expression changes in the brain. — Mol. Brain Res 126: 198-206.
-
Salonen, M., Sulkama, S., Mikkola, S., Puurunen, J., Hakanen, E., Tiira, K., Araujo, C. & Lohi, H. (2020). Prevalence, comorbidity, and breed differences in canine anxiety in 13,700 Finnish pet dogs. — Nature Sci. Rep. 10: 2962. https://doi.org/10.1038/s41598-020-59837-z.
-
Sarviaho, R., Hakosalo, O., Tiira, K., Sulkama, S., Salmela, E., Hytönen, M.K., Sillanpää, M.J. & Lohi, H. (2019). Two novel genomic regions associated with fearfulness in dogs overlap human neuropsychiatric loci. — Transl. Psychiatr. 9: 18.
-
Sarviaho, R., Hakosalo, O., Tiira, K., Sulkama, S., Niskanen, J.E., Hytönen, M.K., Sillanpää, M.J. & Lohi, H. (2020). A novel genomic region on chromosome 11 associated with fearfulness in dogs. — Transl. Psychiatr. 10: 169.
-
Scarlett, J.M., Salman, M.D., New Jr., J.G. & Kass, P.H. (1999). Reasons for relinquishment of companion animals in U.S. animal shelters: selected health and personal issues. — J. Appl. Anim. Welf. Sci. 2: 41-57.
-
Schoenfeld, T.J., McCausland, H.C., Morris, H.D., Padmanaban, V. & Cameron, H.A. (2017). Stress and loss of adult neurogenesis differentially reduce hippocampal volume. — Biol. Psychiatr. 82: 914-923. http://dx.doi.org/10.1016/j.biopsych.2017.05.013.
-
Shekhar, A. (1994). Effects of chronic treatment with imipramine and clonazepam in an animal model of panic disorder. — Biol. Psychiatr. 36: 748-758.
-
Shekhar, A. & Katner, J.S. (1995). GABA-a receptors in the dorsomedial hypothalamus of rats regulate anxiety in the social interaction test. — Pharmacol. Biochem. Behav. 50: 253-258.
-
Shekhar, A., Kiem, S.R., Simon, J.R. & McBride, W.J. (1996). Dorsomedial hypothalamic GABA dysfunction produces physiological arousal following sodium lactate infusions. — Pharmacol. Biochem. Behav. 55: 249-256.
-
Shekhar, A., Sajdyk, T.J., Keim, S.R., Yoder, K.K. & Sanders, S.K. (1999). Role of the basolateral amygdala in panic disorder. — Ann. NY Acad. Sci. 877: 747-750.
-
Shekhar, A., McCann, U.D., Meaney, M.J., Blanchard, D.C., Davis, M., Frey, K.A., Liberzon, I., Overall, K.L., Shear, M.K., Tecott, L.H. & Winsky, L. (2001). Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders. — Psychopharmacology 157: 327-339.
-
Sherman Simpson, B., Landsberg, G.M., Reisner, I.R., Ciribassi, J.J., Horwitz, D., Houpt, K.A., Kroll, T.L., Luescher, A., Moffat, K.S., Douglass, G., Robertson-Plouch, C., Veenhuizen, M.F., Zimmermann, A. & Clark, T.P. (2007). Effects of Reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety. — Vet. Ther. 8: 8-31.
-
Shimada, T., Mimura, M., Inoue, K., Nakamura, S., Oda, H., Ohmori, S. & Yamazaki, H. (1997). Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, Guinea pigs, dogs, monkeys, and humans. — Arch. Toxicol. 71: 401-408.
-
Simpson, B.S. & Papich, M.G. (2003). Pharmacologic management in veterinary behavioral medicine. — Vet. Clin. North. Am.: Small Anim. Pract. 33: 365-404.
-
Stevens, B.J., Frantz, E.M., Orlando, J.M., Griffith, E., Harden, L.B., Gruen, M.E. & Sherman, B.L. (2016). Efficacy of a single dose of trazodone hydrochloride given to cats prior to veterinary visits to reduce signs of transport- and examination related anxiety. — J. Am. Vet. Med. Ass. 249: 202-207.
-
Studzinski, C.M., MacKay, W.A., Beckett, T.L., Henderson, S.T., Murphy, M.P., Sullivan, P.G. & Burnham, W.M. (2008). Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-β precursor protein (APP) levels in the aged dog. — Brain Res. 1226: 209-217.
-
Taha, A.Y., Henderson, S.T. & Burnham, W.M. (2009). Dietary enrichment with medium chain triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of aged dogs: implications for treating age-related cognitive decline. — Neurochem. Res. 34: 1619-1625.
-
Tiira, K. & Lohi, H. (2014). Reliability and validity of a questionnaire survey in canine anxiety research. — Appl. Anim. Behav. Sci. 155: 82-92. https://doi.org/10.1016/j.applanim.2014.03.007.
-
Tiira, K. & Lohi, H. (2015). Early life experiences and exercise associate with canine anxieties. — PLoS ONE 10: e0141907. DOI:10.1371/journal.pone.0141907.
-
Tiira, K., Sulkama, S. & Lohi, H. (2016). Prevalence, comorbidity, and behavioral variation in canine anxiety. — J. Vet. Behav.: Clin. Appl. Res. 16: 36-44, https://doi.org/10.1016/j.jveb.2016.06.008.
-
Van der Borg, J.A.M., Netto, W.J. & Planta, D.J.U. (1991). Behavioural testing of dogs in animal shelters to predict problem behaviour. — Appl. Anim. Behav. Sci. 32: 237-251.
-
van Rooy, D., Haase, B., Mgreevy, P.D., Thomson, P.C. & Wade, C.M. (2016). Evaluating candidate genes oprm1, drd2, avpr1a, and oxtr in golden retrievers with separation-related behaviors. — J. Vet. Behav.: Clin. Appl. Res. 16: 22-27.
-
van Rooy, D., Arnott, E.R., Thomson, P.C., Mgreevy, P.D. & Wade, C.M. (2018). Using an owner-based questionnaire to phenotype dogs with separation-related distress: do owners know what their dogs do when they are absent? — J. Vet. Behav.: Clin. Appl. Res. 23: 58-65.
-
Verbene, G. & DeBoer, J. (1976). Chemocommunication among domestic cats, mediated by the olfactory and vomeronasal senses. I. Communication. — Z. Tierpsychol. 42: 86-109.
-
Wagner, T. & Atlas, L.Y. (2015). The neuroscience of placebo effects: connecting context, learning and health. — Nature Rev. Neurosci. 16: 403-418.
-
Wang, G.-D., Zhai, W., Yang, H.-C., Fan, R.-X., Cao, X., Zhong, L., Wang, L., Liu, F., Wu, H., Cheng, L.-G., Poyarkov, A.D., Poyarkov, N.A., Tang, S.-S., Zhao, W.-M., Gao, Y., Lv, X.-M., Irwin, D.M., Savolainen, P., Wu, C.-I. & Zhang, Y.P. (2013). The genomics of selection in dogs and the parallel evolution between dogs and humans. — Nature Commun. 4: 1860. DOI:10.1038/ncomms2814.
-
Zapata, I., Serpell, J.A. & Alvarez, C.E. (2016). Genetic mapping of canine fear and aggression. — BMC Genomics 17: 572.
-
Zicker, S.C., Jewell, D.E., Yamka, R.M. & Milgram, N.W. (2012). Evaluation of cognitive learning, memory, psychomotor, immunologic, and retinal functions in healthy puppies fed foods fortified with docosahexaenoic acid–rich fish oil from 8 to 52 weeks of age. — J. Am. Vet. Med. Ass. 241: 583-594.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1810 | 284 | 18 |
| Full Text Views | 149 | 10 | 0 |
| PDF Views & Downloads | 221 | 15 | 0 |
Pharmacotherapeutics in clinical ethology: treatment efficacy, clinical pathology and outcome
In: BehaviourSearch for other papers by Karen L. Overall in
Current site
Google Scholar
PubMed
Abstract
The use of psychopharmaceutical agents is a core aspect of treatment in veterinary behavioural medicine. Psychotropic medication use has shifted the focus of treatment from purely behavioural and environmental interventions to a multi-modal approach. Objective measures of efficacy are required for the licensing of medication. Pharmacotherapeutics have come to encompass supplements and diets, in addition to prescription medications. The first part of this paper examines the efficacy of medications, supplements and diets used in behavioural medicine. Foci include the role of evolution in the types of behavioural concerns reported, the importance of defining abnormal or pathological behaviour, use of terminology that supports stratified mechanistic diagnoses aid in understanding presentation and response clusters, and rational use of medication to relieve emotional, mental and behavioural suffering, given these diagnoses and clusters. The second part of this paper examines the extent to which variation in patient response to medication can enlighten us about mechanisms and outcomes of distress using a series of 3 patient populations who are the focus of studies on separation anxiety and noise reactivity. This response surface approach can be useful for understanding differences in populations in susceptibility to behavioural pathology and in medication response, and may suggest new avenues for drug development and application.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1810 | 284 | 18 |
| Full Text Views | 149 | 10 | 0 |
| PDF Views & Downloads | 221 | 15 | 0 |
